Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Livongo Health Inc (LVGO)

Livongo Health Inc (LVGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,563,297
  • Shares Outstanding, K 94,482
  • Annual Sales, $ 68,430 K
  • Annual Income, $ -33,380 K
  • 60-Month Beta N/A
  • Price/Sales 16.95
  • Price/Cash Flow N/A
  • Price/Book 5.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.51 +7.49%
on 02/03/20
28.50 -11.33%
on 02/20/20
-1.94 (-7.13%)
since 01/24/20
3-Month
23.25 +8.69%
on 12/30/19
31.82 -20.58%
on 01/15/20
-3.28 (-11.49%)
since 11/25/19

Most Recent Stories

More News
Options Traders Expect Huge Moves in Livongo (LVGO) Stock

Investors need to pay close attention to Livongo (LVGO) stock based on the movements in the options market lately.

LVGO : 25.27 (-6.86%)
Livongo and Dexcom Partner to Integrate Dexcom's G6 Continuous Glucose Monitoring System into Livongo's Applied Health Signals Platform

Livongo (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, has partnered with Dexcom, Inc. (NASDAQ: DXCM), a leader in...

LVGO : 25.27 (-6.86%)
DXCM : 283.96 (-3.43%)
Livongo to Present at J.P. Morgan 38th Annual Healthcare Conference

Livongo Health, Inc., (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the Company will be participating...

JPM : 126.26 (-4.46%)
LVGO : 25.27 (-6.86%)
Livongo Earns Preferred Status on New Express Scripts Digital Health Formulary

Livongo (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced it will be included on Express Scripts new,...

ESRX : 92.33 (-3.62%)
LVGO : 25.27 (-6.86%)
Livongo Health: 3Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Livongo Health Inc. (LVGO) on Wednesday reported a loss of $19.7 million in its third quarter.

LVGO : 25.27 (-6.86%)
Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023

Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases - trends that expand healthcare spending....

MHMNF : 54.5000 (unch)
SOLY : 11.86 (-1.33%)
AKCA : 17.10 (+1.82%)
LVGO : 25.27 (-6.86%)
PFNX : 12.66 (-0.55%)
GILD : 70.10 (-3.84%)
Livongo to Present at Morgan Stanley 17th Annual Healthcare Conference

Livongo Health, Inc. (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the Company will be participating...

MS : 48.03 (-3.32%)
LVGO : 25.27 (-6.86%)
Revenues For Connected Medical Device Market Expected to Reach $6 Billion

Every day consumers become more and more connected via their smart phones and other devices for banking, entertainment and a host of other applications. Health will be one of the fastest growing sectors...

DRIO : 8.32 (-5.45%)
LVGO : 25.27 (-6.86%)
HCAT : 29.57 (-1.79%)
PHR : 30.46 (-4.27%)
MYL : 19.90 (-2.02%)
Livongo Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Livongo Health, Inc., (Nasdaq: LVGO) today announced the closing of its initial public offering of 14,590,050 shares of its common stock at a price of $28.00 per share, which includes the full exercise...

MS : 48.03 (-3.32%)
LVGO : 25.27 (-6.86%)
Trade LVGO with:

Business Summary

Livongo Health Inc. is a consumer digital health company. It offers Enter Livongo platform, which leverages data science and technology, for people with chronic conditions. The Company's Livongo platform offers solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes...

See More

Key Turning Points

2nd Resistance Point 28.56
1st Resistance Point 26.91
Last Price 25.27
1st Support Level 24.21
2nd Support Level 23.16

See More

52-Week High 45.68
Fibonacci 61.8% 34.01
Fibonacci 50% 30.40
Fibonacci 38.2% 26.79
Last Price 25.27
52-Week Low 15.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar